Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments - Takeaways - MDSpire

Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments

  • By

  • Carolina Schwedhelm

  • Leonie Kunk

  • Dorota Pawlowska-Phelan

  • Olaf Behmer

  • Anja Plenske

  • Jessica Herrath

  • Diamant Thaçi

  • Agnes Kisser

  • April 13, 2026

  • 0 min

Share

  • 1

    The study estimated a 1-year administrative prevalence of atopic dermatitis (AD) in Germany at 2.4%, highest in children aged 0-4 years.

  • 2

    Indicators of insufficient disease control in AD patients included infections, prolonged topical treatment, and a high number of active flares.

  • 3

    Current systemic therapies for AD have limitations, particularly for long-term use and in patients aged ≤ 18 years.

  • 4

    The study utilized claims data from a representative sample of the German population to analyze AD treatment patterns.

  • 5

    There is a need for improved understanding of systemic therapy use and disease control in patients with atopic dermatitis.

Original Source(s)

Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments

  • by Carolina Schwedhelm, Leonie Kunk, Dorota Pawlowska-Phelan, Olaf Behmer, Anja Plenske, Jessica Herrath, Diamant Thaçi, Agnes Kisser

  • April 13, 2026

Related Content

Does Air Pollution Affect Skin Health?

Large systematic review finds consistent associations across conditions but highlights low certainty driven by bias and study heterogeneity.

Editorial: Exploring Cutaneous Drug-Related and Drug-Associated Adverse events: from Clinical Insights to Therapeutic Management

Gene Test Guides Eczema Care

Skin scraping assay may help labs support targeted systemic treatment in atopic dermatitis

  • March 2, 2026

  • 3 min